Mark A. McCormick and Brian K. Kennedy Pages 500 - 507 ( 8 )
Whole-genome studies involving a phenotype of interest are increasingly prevalent, in part due to a dramatic increase in speed at which many high throughput technologies can be performed coupled to simultaneous decreases in cost. This type of genome-scale methodology has been applied to the phenotype of lifespan, as well as to wholetranscriptome changes during the aging process or in mutants affecting aging. The value of high throughput discoverybased science in this field is clearly evident, but will it yield a true systems-level understanding of the aging process? Here we review some of this work to date, focusing on recent findings and the unanswered puzzles to which they point. In this context, we also discuss recent technological advances and some of the likely future directions that they portend.
Aging, Genomic, High-throughput, Lifespan, Whole-genome, Yeast, C. elegans
Buck Institute for Research on Aging, 8001 Redwood Blvd. Novato, CA 94945, USA.